Therapeutic drug monitoring of mycophenolate mofetil in transplantation. - Wikidata - awgldk - TriplyDB

Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

http://www.wikidata.org/entity/Q36455259

about

Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT.Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients.Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis.Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients.Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients.Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation.Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation.A limited sampling strategy for estimation of the area under the curve (0 to 8 hours) of mycophenolic acid administered three times daily to liver transplant recipients Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection.Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients.Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation.New-onset diabetes after renal transplantation: risk assessment and management.A comprehensive review of the published assays for the quantitation of the immunosuppressant drug mycophenolic acid and its glucuronidated metabolites in biological fluids.Time-dependent clearance of mycophenolic acid in renal transplant recipients Effects of gastric emptying on oral mycophenolic acid pharmacokinetics in stable renal allograft recipients.Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9.Safety considerations with mycophenolate sodium.A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation.Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes.Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.Estimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium.State of the art in therapeutic drug monitoring.Pharmacogenetic influences on mycophenolate therapy.LC-MS/MS for immunosuppressant therapeutic drug monitoring.The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune disease Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.Genes and beans: pharmacogenomics of renal transplant.How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?Acute mycophenolate overdose: case series and systematic literature analysis.Clinical Pharmacokinetics of Mycophenolic Acid in Hematopoietic Stem Cell Transplantation Recipients.

P2860

Q28272907-09A7BDB0-F131-4151-AAAE-E0664FCC6225 Q33551422-E9A0CBC4-BF83-4D3D-9F49-A55E483C13EA Q33684048-AE2F231F-02F4-40A2-B128-1B56AB4E9B7A Q33696568-68819CA5-588F-4936-8B9C-35FC20F91C69 Q33728060-099B7B3A-FA6C-4D47-940A-9DE6A38584E3 Q33764989-4C32DECF-BD0C-48ED-B449-6AB2E1460BD0 Q33764995-903668DB-7686-472C-BB5F-D488579E9830 Q34077882-27E06A54-4D99-4AF4-A1C3-61165975C6DB Q34180482-9B028947-21B2-4CE5-B084-F5E2DA119570 Q34287623-9A4F3CB0-A1B9-4B4C-8987-6B9B0B24382C Q34339626-1F462B3C-CDFB-42BC-B277-640C1B4D2492 Q34577357-4858D7D0-307D-4F1F-AEEA-DA96B431923A Q34607590-B9398A28-4E30-4A75-A542-84A2A378FB65 Q34610933-F4D073FE-8F4B-451F-98A2-55DC0C81277C Q34947658-ABF85F1C-C0AE-46E5-BD45-A045DDBDE57E Q35486258-327BECC4-5FBD-473A-A42D-30070EEAB070 Q35620221-F636BD6D-EDDE-4EE1-8807-B9A3B6743032 Q35893989-E32F4F4D-0255-47EE-9A38-4104CC360B9C Q36024478-C21A88C2-3215-4465-80B0-C132BA04028B Q36025085-88A67236-ACB7-4534-BCA9-93F800E50071 Q36379888-3F85481C-7D30-4807-BEBD-16713542F181 Q36400272-8546AD49-AD9E-4FF9-848C-08553C038B2D Q36724093-AD4DA0AB-5BFC-47D6-8508-BF24E22F7812 Q36788423-3524BA6A-61DF-43F4-A9A4-3515770E8210 Q36792638-239301A6-E2F3-4AF4-8D83-55B64F66398B Q36905861-FB68FA6B-7E91-42C5-A9EA-53EED8CAD05F Q37086991-45B2DCB2-86EB-47CB-848E-244BA35985AB Q37112472-70FA2383-4B4B-45C5-AF60-16A0567B019E Q37438051-4CD76249-55F9-4918-9389-B42E8D4416AB Q37441778-7BCB4AB9-4106-4451-96BC-9C2E780061A5 Q37582505-51432BD7-4FB4-4B01-B2A2-10D8ECCA4A47 Q37699413-EE7EB4AE-439D-4F91-B2FD-DF9B3317351D Q37710509-A5F35713-5AA4-4DF0-9C96-A57412CB9E15 Q37810219-CDF25A2E-0E61-4054-A1C3-849EC78E6942 Q37818144-D4493330-B23E-4BBF-8EDC-87B0AB65F68E Q38087925-4671D569-24DF-4508-9BD9-D33AD42A8C22 Q38104742-83425E29-EB96-4EDA-857E-7D23A840B921 Q38170321-3B04D04D-9F62-4F96-B3A1-9F03A877DB2D Q38198150-2F81AB58-891E-433D-B04A-18406050C70A Q38817096-4656A9E9-86DC-407D-9423-4158C37D61BC

P2860

Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

http://www.wikidata.org/entity/Q36455259

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

@ast

Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

@en

type

label

Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

@ast

Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

@en

prefLabel

Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

@ast

Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

@en

P1433

Q36455259-FEDFDEE7-EE6D-4867-BAC3-D2F54A8323B9

P1476

Q36455259-F63C234B-9AD7-40EB-97F4-A395997C304F

P2093

Q36455259-00EABFA0-6B04-47EC-9FB4-C6C51C75E4A1

Q36455259-4938AD78-7E7B-494E-A8EF-315D8FB3FC2C

Q36455259-5B790805-00BF-498A-BE59-A4974AE4248D

Q36455259-5EC254A5-2F37-4257-8F02-5A157D12CB43

Q36455259-8448F353-0F21-43A6-912C-4F9CC2C66F30

Q36455259-88ECB957-8646-4EFA-AD60-83027E448138

Q36455259-9F09E2E2-394C-4662-AF53-D8012E29802E

Q36455259-B605315E-0870-484A-B5E9-18EB5A723840

Q36455259-BDC0341F-5736-459D-8456-C85245241D66

Q36455259-C470B6B6-E16A-4A9C-9FF4-522C78A8BB84

P304

Q36455259-DC6CD7E6-F328-4270-8E67-10F7A7A18C91

P31

Q36455259-889EDF93-35DA-467C-A96B-17EDCCDB1C30

Q36455259-ad72a799-ccbf-4f21-a30e-6f65ec5ec5fd

P356

Q36455259-C8205DB7-29E7-4681-B2E5-7EE36C38F5C6

P433

Q36455259-B499C1F5-1D98-452E-A927-5EC4CB1D515D

P478

Q36455259-AAEA33E2-DB06-47A3-83F4-B5E954346AD8

P577

Q36455259-62970273-30D0-46D2-95DB-4A420CA6EC35

P698

Q36455259-E484D008-6C44-4087-86CE-144EAE01BD17

P356

01.FTD.0000199358.80013.BD

P1433

Therapeutic Drug Monitoring

P1476

Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

@en

P2093

Bruce Kaplan

http://www.w3.org/2001/XMLSchema#string

Bruno Meiser

http://www.w3.org/2001/XMLSchema#string

Burkhard Toenshoff

http://www.w3.org/2001/XMLSchema#string

Curtis Holt

http://www.w3.org/2001/XMLSchema#string

David DeNofrio

http://www.w3.org/2001/XMLSchema#string

David W Holt

http://www.w3.org/2001/XMLSchema#string

Dirk Kuypers

http://www.w3.org/2001/XMLSchema#string

Leslie M Shaw

http://www.w3.org/2001/XMLSchema#string

Michael Oellerich

http://www.w3.org/2001/XMLSchema#string

Richard D Mamelok

http://www.w3.org/2001/XMLSchema#string

P304

145-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.FTD.0000199358.80013.BD

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16628123

http://www.w3.org/2001/XMLSchema#string